National Notifiable Diseases Surveillance System, 1 October to 31 December 2014

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the reporting period 1 October to 31 December 2014.

Page last updated: 31 May 2015

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 57,995 notifications to the National Notifiable Diseases Surveillance System with a notification received date between 1 October to 31 December 2014 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).

NEC Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
All jurisdictions
Hepatitis B (newly acquired)
All jurisdictions
Hepatitis B (unspecified)
All jurisdictions
Hepatitis C (newly acquired)
All jurisdictions except Queensland
Hepatitis C (unspecified)
All jurisdictions
Hepatitis D
All jurisdictions
Gastrointestinal diseases
Botulism
All jurisdictions
Campylobacteriosis
All jurisdictions except New South Wales
Cryptosporidiosis
All jurisdictions
Haemolytic uraemic syndrome
All jurisdictions
Hepatitis A
All jurisdictions
Hepatitis E
All jurisdictions
Listeriosis
All jurisdictions
STEC, VTEC*
All jurisdictions
Salmonellosis
All jurisdictions
Shigellosis
All jurisdictions
Typhoid
All jurisdictions
Quarantinable diseases
Cholera
All jurisdictions
Highly pathogenic avian influenza in humans
All jurisdictions
Plague
All jurisdictions
Rabies
All jurisdictions
Severe acute respiratory syndrome
All jurisdictions
Smallpox
All jurisdictions
Viral haemorrhagic fever
All jurisdictions
Yellow fever
All jurisdictions
Sexually transmissible infections
Chlamydial infection
All jurisdictions
Donovanosis
All jurisdictions
Gonococcal infection
All jurisdictions
Syphilis - congenital
All jurisdictions
Syphilis <2 years duration
All jurisdictions
Syphilis >2 years or unspecified duration
All jurisdictions
Vaccine preventable diseases
Diphtheria
All jurisdictions
Haemophilus influenzae type b
All jurisdictions
Influenza (laboratory confirmed)
All jurisdictions
Measles
All jurisdictions
Mumps
All jurisdictions
Pertussis
All jurisdictions
Pneumococcal disease (invasive)
All jurisdictions
Poliomyelitis
All jurisdictions
Rubella
All jurisdictions
Rubella - congenital
All jurisdictions
Tetanus
All jurisdictions
Varicella zoster (chickenpox)
All jurisdictions except New South Wales
Varicella zoster (shingles)
All jurisdictions except New South Wales
Varicella zoster (unspecified)
All jurisdictions except New South Wales
Vectorborne diseases
Arbovirus infection (NEC)
All jurisdictions
Barmah Forest virus infection
All jurisdictions
Dengue virus infection
All jurisdictions
Japanese encephalitis virus infection
All jurisdictions
Kunjin virus infection
All jurisdictions
Malaria
All jurisdictions
Murray Valley encephalitis virus infection
All jurisdictions
Ross River virus infection
All jurisdictions
Zoonoses
Anthrax
All jurisdictions
Australian bat lyssavirus
All jurisdictions
Brucellosis
All jurisdictions
Leptospirosis
All jurisdictions
Lyssavirus (NEC)
All jurisdictions
Ornithosis
All jurisdictions
Q fever
All jurisdictions
Tularaemia
All jurisdictions
Other bacterial infections
Legionellosis
All jurisdictions
Leprosy
All jurisdictions
Meningococcal infection
All jurisdictions
Tuberculosis
All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 October to 31 December 2014, by date of diagnosis*
  State or territory Total 4th quarter 2014 Total 3rd quarter 2014 Total 4th quarter 2013 Last 5 years mean 4th quarter Ratio Year to date 2014 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas Vic WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis   unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

¶ The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Bloodborne diseases
Hepatitis (NEC)
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Hepatitis B (newly acquired)
0 5 1 12 0 0 9 6 33 36 44 50.2 0.7 173 208.8
Hepatitis B (unspecified)
24 593 31 251 94 15 432 151 1,591 1,708 1,730 1,657.0 1.0 6,562 6,815.4
Hepatitis C (newly acquired)
0 4 0 0 7 2 40 31 84 97 117 106.0 0.8 387 424.8
Hepatitis C (unspecified)
38 847 48 642 115 56 513 279 2,538 2,666 2,595 2,526.6 1.0 10,259 10,387.4
Hepatitis D
0 7 1 1 0 0 0 2 11 12 13 9.2 1.2 50 38.8
Gastrointestinal diseases
Botulism
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 1 1.4
Campylobacteriosis
125 NN 84 1,785 540 265 2,015 883 5,697 4,758 4,491 4,486.8 1.3 19,898 16,235.4
Cryptosporidiosis
2 123 18 87 54 6 107 69 466 414 574 417.2 1.1 2,403 2,981.0
Haemolytic uraemic syndrome
0 2 0 0 0 0 1 0 3 4 6 3.8 0.8 20 14.0
Hepatitis A
0 25 0 6 2 0 14 4 51 51 33 82.6 0.6 227 266.0
Hepatitis E
0 4 0 3 0 0 5 0 12 9 12 7.2 1.7 53 35.4
Listeriosis
1 5 2 4 0 2 4 2 20 18 15 20.6 1.0 80 80.4
STEC, VTEC§
0 3 0 6 9 0 2 0 20 22 29 31.0 0.6 116 118.6
Salmonellosis
59 1,092 113 1,323 294 71 948 303 4,203 2,745 3,390 2,887.2 1.5 16,370 11,545.8
Shigellosis
0 39 28 68 11 1 110 33 290 249 159 135.6 2.1 1,063 549.6
Typhoid
1 13 0 2 3 1 5 4 29 22 39 30.6 0.9 120 124.6
Quarantinable diseases
Cholera
0 0 0 0 0 0 0 0 0 0 2 0.4 0.0 2 4.2
Highly pathogenic avian influenza in humans
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Plague
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Rabies
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Severe acute respiratory syndrome
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Smallpox
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Viral haemorrhagic fever
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Yellow fever
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.7
Sexually transmissible infections
Chlamydial infection||,¶
284 5,483 761 4,736 1,156 417 4,508 2,732 20,077 20,651 20,287 18,603.4 1.1 85,662 76,758.6
Donovanosis
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.6
Gonococcal infection
28 1,167 380 621 147 20 885 511 3,759 3,653 3,622 2,998.0 1.3 15,703 11,900.4
Syphilis – congenital
0 0 1 0 0 0 0 0 1 4 1 0.6 1.7 5 4.2
Syphilis < 2 years duration
3 152 27 76 10 6 180 22 476 538 440 336.4 1.4 1,975 1,417.4
Syphilis > 2 years or unspecified duration‡,¶
9 124 34 57 23 6 161 18 432 453 404 337.6 1.3 1,822 1,422.8
Vaccine preventable diseases
Diphtheria
0 0 0 1 0 0 0 0 1 1 1 0.2 5.0 2 1.2
Haemophilus influenzae type b
0 1 0 3 0 0 2 0 6 6 4 3.6 1.7 21 18.2
Influenza (laboratory confirmed)
113 1,124 112 1,742 1,396 59 1,123 620 6,289 53,141 6,457 3,465.6 1.8 67,854 34,522.8
Measles
0 1 4 18 1 0 8 4 36 57 87 37.2 1.0 340 145.0
Mumps
0 15 0 7 11 0 1 5 39 46 40 36.8 1.1 187 167.4
Pertussis
56 1,421 16 215 146 10 1,844 530 4,238 3,137 3,203 8,257.6 0.5 11,830 28,029.6
Pneumococcal disease (invasive)
3 123 9 41 23 11 88 53 351 589 341 360.0 1.0 1,562 1,690.6
Poliomyelitis
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Rubella
0 3 0 0 0 0 2 0 5 3 6 5.4 0.9 17 38.2
Rubella – congenital
0 0 0 0 0 0 0 0 0 0 1 0.2 0.0 0 0.6
Tetanus
0 0 0 1 0 0 0 1 2 0 0 0.8 2.5 3 3.8
Varicella zoster (chickenpox)
12 NN 13 70 91 15 251 114 566 540 689 570.4 1.0 2,082 1,959.4
Varicella zoster (shingles)
38 NN 67 11 504 69 344 385 1,418 1,328 1,403 1,034.4 1.4 5,531 3,877.8
Varicella zoster (unspecified)
34 NN 3 1,416 59 36 977 300 2,825 2,703 2,710 2,175.2 1.3 10,778 7,997.6
Vectorborne diseases
Arbovirus infection (NEC)
1 22 7 56 0 0 7 8 101 90 459 432.4 0.2 739 2,154.8
Barmah Forest virus infection
0 10 0 18 2 0 13 5 48 17 11 14.2 3.4 106 56.6
Dengue virus infection
0 0 0 3 0 0 0 0 3 2 4 3.2 0.9 29 13.6
Japanese encephalitis virus infection
0 0 0 0 0 0 0 0 0 1 0 0.0 0.0 1 1.0
Kunjin virus infection**
0 0 0 0 0 0 0 0 0 0 2 0.6 0.0 1 1.6
Malaria
1 11 3 22 1 1 13 11 63 81 88 98.6 0.6 318 418.4
Murray Valley encephalitis virus infection**
0 0 0 0 0 0 0 0 0 0 0 0.2 0.0 0 4.4
Ross River virus infection
3 218 65 796 23 2 80 332 1,519 879 966 849.6 1.8 5,329 4,800.6
Zoonoses
Anthrax
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.2
Australian bat lyssavirus
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.2
Brucellosis
0 0 0 3 0 0 0 0 3 5 6 7.2 0.4 17 27.0
Leptospirosis
0 4 1 3 0 0 1 1 10 17 20 20.6 0.5 85 137.8
Lyssavirus (NEC)
0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Ornithosis
0 5 0 2 0 0 6 0 13 9 15 23.8 0.5 39 66.6
Q fever
1 50 0 36 1 0 9 1 98 117 124 94.0 1.0 459 373.2
Tularaemia
0 0 0 0 0 0 0 0 0 0 0 0.3 0.0 0 0.7
Other bacterial infections
Legionellosis
2 20 0 22 9 1 15 44 113 111 124 95.8 1.2 425 370.4
Leprosy
0 0 0 0 1 0 0 1 2 0 4 2.8 0.7 9 9.4
Meningococcal infection††
0 14 0 7 10 0 10 5 46 57 34 48.4 1.0 169 220.4
Tuberculosis
10 120 9 47 13 4 133 31 367 351 325 378.6 1.0 1,337 1,326.8
Total
848 12,850 1,838 14,220 4,756 1,076 14,866 7,501 57,955 101,398 55,127     272,221  

Top of page

Table 3: Notification rates of diseases, 1 October to 31 December 2014, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

** The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

‡‡ Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.
Bloodborne diseases
Hepatitis (NEC)
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Hepatitis B (newly acquired)
0.0 0.3 1.7 1.0 0.0 0.0 0.6 1.0 0.6
Hepatitis B (unspecified)§
25.2 32.0 51.4 21.6 22.5 11.7 30.1 24.0 27.5
Hepatitis C (newly acquired)
0.0 0.2 0.0 0.0 1.7 1.6 2.8 4.9 1.5
Hepatitis C (unspecified)§
39.8 45.7 79.6 55.2 27.5 43.7 35.8 44.3 43.9
Hepatitis D
0.0 0.4 1.7 0.1 0.0 0.0 0.0 0.3 0.2
Gastrointestinal diseases
Botulism
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Campylobacteriosis
131.1 NN 139.3 153.4 129.3 206.6 140.4 140.1 144.9
Cryptosporidiosis
2.1 6.6 29.9 7.5 12.9 4.7 7.5 10.9 8.1
Haemolytic uraemic syndrome
0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1
Hepatitis A
0.0 1.3 0.0 0.5 0.5 0.0 1.0 0.6 0.9
Hepatitis E
0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.2
Listeriosis
1.0 0.3 3.3 0.3 0.0 1.6 0.3 0.3 0.3
STEC,VTEC||
0.0 0.2 0.0 0.5 2.2 0.0 0.1 0.0 0.3
Salmonellosis
61.9 59.0 187.4 113.7 70.4 55.3 66.1 48.1 72.7
Shigellosis
0.0 2.1 46.4 5.8 2.6 0.8 7.7 5.2 5.0
Typhoid fever
1.0 0.7 0.0 0.2 0.7 0.8 0.3 0.6 0.5
Quarantinable diseases
Cholera
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Human pathogenic avian influenza in humans
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Plague
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rabies
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Severe acute respiratory syndrome
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Smallpox
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Viral haemorrhagic fever
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Yellow fever
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sexually transmitted infections
Chlamydial infection¶,**
297.8 296.0 1,262.0 407.0 276.8 325.1 314.2 433.6 347.1
Donovanosis
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Gonococcal infection**
29.4 63.0 630.2 53.4 35.2 15.6 61.7 81.1 65.0
Syphilis – congenital
0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0
Syphilis < 2 years duration**
3.1 8.2 44.8 6.5 2.4 4.7 12.5 3.5 8.2
Syphilis > 2 years or unspecified duration§,**
9.4 6.7 56.4 4.9 5.5 4.7 11.2 2.9 7.5
Vaccine preventable diseases
Diphtheria
0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Haemophilus influenzae type b
0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1
Influenza (laboratory confirmed)
118.5 60.7 185.7 149.7 334.2 46.0 78.3 98.4 108.7
Measles
0.0 0.1 6.6 1.5 0.2 0.0 0.6 0.6 0.6
Mumps
0.0 0.8 0.0 0.6 2.6 0.0 0.1 0.8 0.7
Pertussis
58.7 76.7 26.5 18.5 35.0 7.8 128.5 84.1 73.3
Pneumococcal disease (invasive)
3.1 6.6 14.9 3.5 5.5 8.6 6.1 8.4 6.1
Poliomyelitis
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rubella
0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1
Rubella – congenital
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tetanus
0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0
Varicella zoster (chickenpox)
12.6 NN 21.6 6.0 21.8 11.7 17.5 18.1 14.4
Varicella zoster (shingles)
39.8 NN 111.1 0.9 120.7 53.8 24.0 61.1 36.1
Varicella zoster (unspecified)
35.7 NN 5.0 121.7 14.1 28.1 68.1 47.6 71.9
Vectorborne diseases
Arbovirus infection (NEC)
1.0 1.2 11.6 4.8 0.0 0.0 0.5 1.3 1.7
Barmah Forest virus infection
0.0 0.5 0.0 1.5 0.5 0.0 0.9 0.8 0.8
Dengue virus infection
0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1
Japanese encephalitis virus infection
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Kunjin virus infection††
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Malaria
1.0 0.6 5.0 1.9 0.2 0.8 0.9 1.7 1.1
Murray Valley encephalitis virus infection††
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ross River virus infection
3.1 11.8 107.8 68.4 5.5 1.6 5.6 52.7 26.3
Zoonoses
Anthrax
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Australia bat lyssavirus
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Brucellosis
0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1
Leptospirosis
0.0 0.2 1.7 0.3 0.0 0.0 0.1 0.2 0.2
Lyssavirus (NEC)
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ornithosis
0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.2
Q fever
1.0 2.7 0.0 3.1 0.2 0.0 0.6 0.2 1.7
Tularaemia
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other bacterial diseases
Legionellosis
2.1 1.1 0.0 1.9 2.2 0.8 1.0 7.0 2.0
Leprosy
0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0
Meningococcal infection‡‡
0.0 0.8 0.0 0.6 2.4 0.0 0.7 0.8 0.8
Tuberculosis
10.5 6.5 14.9 4.0 3.1 3.1 9.3 4.9 6.3

Top of page

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now